TP53 and mycosis fungoides: Findings revealed that the expression level of miR-34a tended to decrease in MF patients when compared to healthy controls, while NEAT-1 and p53 levels were higher in MF patients than that in controls reporting a significant difference regarding the biomarkers between both groups.